The following pages link to (Q4704712):
Displaying 21 items.
- A Bayesian adaptive design for two-stage clinical trials with survival data (Q745979) (← links)
- Basic concepts of group sequential and adaptive group sequential test procedures (Q1580842) (← links)
- Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
- Optimal two-stage group-sequential designs (Q2475735) (← links)
- On the efficiency of adaptive designs for flexible interim decisions in clinical trials (Q2492935) (← links)
- (Q2755673) (← links)
- Sequential Methods in Multi-Arm Clinical Trials (Q3068083) (← links)
- Monitoring Clinical Trials with Multiple Arms (Q3078836) (← links)
- Sequential Tests for Noninferiority and Superiority (Q3079082) (← links)
- An Approach to the Conditional Error Rate Principle with Nuisance Parameters (Q3100810) (← links)
- Adaptive Design for Censored Survival Data Adjusting for Covariates (Q3430296) (← links)
- Optimal Conditional Error Functions for the Control of Conditional Power (Q3445294) (← links)
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials (Q3527716) (← links)
- A Two-Stage Procedure for Comparing Hazard Rate Functions (Q3631451) (← links)
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs (Q4430337) (← links)
- Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069) (← links)
- Interim Analysis and Sample Size Reassessment (Q4670476) (← links)
- A comparison between two treatments in a clinical trial with an ethical allocation design (Q5107007) (← links)
- Discussion on “Second-Guessing Clinical Trial Designs” by Jonathan J. Shuster and Myron N. Chang (Q5458022) (← links)
- A distribution-free approach for selecting better treatment through an ethical allocation (Q5742408) (← links)
- Sample size reassessment for a two-stage design controlling the false discovery rate (Q5962696) (← links)
